In separate regulatory filings on Monday, both companies said NCLT had sanctioned the scheme of amalgamation under Sections 230 to 232 of the Companies Act
The National Company Law Tribunal (NCLT) has approved the merger of JB Chemicals & Pharmaceuticals Ltd with Torrent Pharmaceuticals Ltd, clearing a key regulatory hurdle for one of the largest consolidation deals in India’s pharmaceutical sector.In separate regulatory filings on Monday, both companies said NCLT had sanctioned the scheme of amalgamation under Sections 230 to 232 of the Companies Act. The merger will become effective after the certified copy of the tribunal’s order is filed with the Registrar of Companies (RoC), following which the companies will announce the effective date. The approval follows shareholders of both companies voting in favour of the scheme at NCLT-convened meetings held in April this year.Torrent had announced the acquisition of JB Chemicals in 2025 as part of its strategy to strengthen its domestic formulations business and expand its presence in international markets. The transaction is also expected to provide Torrent an entry into newer therapy segments such as ophthalmology and IVF, while complementing its existing strengths in cardiology, gastroenterology and paediatrics.The merger will also enhance Torrent’s international footprint, particularly in Russia, South Africa and the US, while providing it with an entry into the contract development and manufacturing organisation (CDMO) business through JB Chemicals’ existing operations. At the time of announcing the acquisition, Torrent’s management had said the transaction would generate procurement synergies, improve manufacturing utilisation and strengthen its prescription reach in the Indian pharmaceutical market. JB Chemicals operates eight manufacturing plants, employs around 5,600 people and reported a consolidated turnover of ₹3,918 crore for FY25.Published on July 6, 2026
